Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib

被引：51

作者：

Breccia, M. ^{[1
,2
]}

Muscaritoli, M. ^{[3
]}

Cannella, L. ^{[2
]}

Stefanizzi, C. ^{[2
]}

Frustaci, A. ^{[2
]}

Alimena, G. ^{[2
]}

机构：

[1] Dept Human Biotechnol & Hematol, I-00161 Rome, Italy

[2] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy

[3] Univ Roma La Sapienza, Dept Clin Med, Rome, Italy

来源：

LEUKEMIA RESEARCH | 2008年 / 32卷 / 10期

关键词：

D O I：

10.1016/j.leukres.2008.01.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1626 / 1628

页数：3

共 7 条

[1] Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation [J].

Barnes, K ;

McIntosh, E ;

Whetton, AD ;

Daley, GQ ;

Bentley, J ;

Baldwin, SA .

ONCOGENE, 2005, 24 (20) :3257-3267

[2]

Boren J, 2001, J BIOL CHEM, V276, P37747

[3] Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib [J].

Breccia, M. ;

Muscaritoli, M. ;

Gentilim, F. ;

Latagliata, R. ;

Carmosino, I. ;

Fanelli, F. Rossi ;

Alimena, G. .

LEUKEMIA RESEARCH, 2007, 31 (12) :1770-1772

[4] Imatinib mesylate may improve fasting blood glucose in diabetic Ph plus chronic myelogenous leukemia patients responsive to treatment [J].

Breccia, M ;

Muscaritoli, M ;

Aversa, Z ;

Mandelli, F ;

Alimena, G .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) :4653-4655

[5] Inhibitory role of Src family tyrosine kinases on Ca2+-dependent insulin release [J].

Cheng, Haiying ;

Straub, Susanne G. ;

Sharp, Geoffrey W. G. .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (03) :E845-E852

[6] Amelioration of diabetes by imatinib mesylate (Gleevec®):: role of β-cell NF-κB activation and anti-apoptotic preconditioning [J].

Hagerkvist, Robert ;

Sandler, Stellan ;

Mokhtari, Dariush ;

Welsh, Nils .

FASEB JOURNAL, 2007, 21 (02) :618-628

[7] Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias [J].

Talpaz, Moshe ;

Shah, Neil P. ;

Kantarjian, Hagop ;

Donato, Nicholas ;

Nicoll, John ;

Paquette, Ron ;

Cortes, Jorge ;

O'Brien, Susan ;

Nicaise, Claude ;

Bleickardt, Eric ;

Blackwood-Chirchir, M. Anne ;

Iyer, Vishwanath ;

Chen, Tai-Tsang ;

Huang, Fei ;

Decillis, Arthur P. ;

Sawyers, Charles L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24) :2531-2541

← 1 →